SpiroChem

Zurich, Switzerland Founded: 2011 • Age: 15 yrs
Swiss fine chemicals company providing API, Intermediates and custom synthesis services for the pharma and biotech industry

About SpiroChem

SpiroChem is a Healthcare company based in Zurich (Switzerland) founded in 2011. Swiss fine chemicals company providing API, Intermediates and custom synthesis services for the pharma and biotech industry. SpiroChem has completed 1 acquisition, including Cyclenium Pharma. Its focus areas include Biopharma Outsourcing, CRO, Drug Discovery and Medicinal Chemistry. Its legal entity is SpiroChem AG.

Company details

SpiroChem was founded in 2011 in Zurich, Switzerland, as a fine chemicals company. Active pharmaceutical ingredients, intermediates, and custom synthesis services are supplied to the pharmaceutical and biotechnology sectors. Customized libraries of intermediates are developed based on client specifications. Operations focus on supporting research and development needs in these industries.

  • Headquarters Zurich, Switzerland
  • Sectors
    Healthcare
  • Website spirochem.com
  • Social LinkedIn X
  • Legal Name Spirochem Ag
Key Metrics

Funding Insights of SpiroChem

  • Total Rounds 3
  • Last Round Grant β€” $600,757
  • First Round $11,324

    (Jun 2011)

  • Investors Count 2

All 3 funding rounds of SpiroChem with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2020$600,757Grant––
Jul 2014Grant––
–
Jun 2011$11,324Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in SpiroChem

SpiroChem has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and Venture Kick.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
University backed startup accelerator
venturekick.chSchlieren, Switzerland
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for SpiroChem

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of SpiroChem

7 people are tracked at SpiroChem (4 in leadership, 3 in team).

NameRoleGroup
Anna Wozniak
Chief Financial OfficerLeadership
Thomas Fessard
CEOLeadership
Gerhard Müller
Chief Scientific OfficerLeadership
Florent Beaufils
Chief Operating OfficerLeadership
Colin Bournez
Research Scientist - Computational ChemistTeam
Sylvain Blanc
Research ChemistTeam
Laurence Jung
Innovative Solutions DeveloperTeam
Premium access

Complete people profiles for SpiroChem

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by SpiroChem

SpiroChem has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Cyclenium Pharma.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Canadian, preclinical-stage biopharma developing macrocycle drugs for oncology, infections, and pain
cyclenium.comMontreal, Canada2013Jun 2023β€’β€’β€’β€’
Premium access

Complete acquisition details for SpiroChem

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of SpiroChem

4 dated milestones of SpiroChem across 12 years, from founding to its latest funding, stage changes and deals.

  1. Founded SpiroChem is founded.
  2. Funding First funding round of $11K.
  3. Funding Latest funding round, Grant, of $601K.
  4. Acquisition Acquires Cyclenium Pharma.

Web traffic of SpiroChem

The website of SpiroChem (spirochem.com) receives about 1.1K visits a month.

  • Monthly visits
    1.1K

    ▼ 44.3% vs previous month

Similar websites

Websites whose visitors overlap most with SpiroChem. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
leatherchemists.org
leatherchemists.org
100%
#11,900,110–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Spirochem

Premium access

Complete news archive for SpiroChem

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about SpiroChem

SpiroChem was founded in 2011.

SpiroChem is headquartered in Zurich, Switzerland.

SpiroChem was founded in 2011 in Zurich, Switzerland, as a fine chemicals company. Active pharmaceutical ingredients, intermediates, and custom synthesis services are supplied to the pharmaceutical and biotechnology sectors. Customized libraries of intermediates are developed based on client specifications. Operations focus on supporting research and development needs in these industries.

SpiroChem has made 1 acquisition, including Cyclenium Pharma.

SpiroChem has 2 investors. Key investors include European Union, and Venture Kick.

SpiroChem operates through Spirochem Ag.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available